The document summarizes the origins and operations of the Pistoia Alliance, a non-profit organization formed to facilitate pre-competitive collaboration in the life sciences industry. The Pistoia Alliance was formed in Pistoia, Italy by GSK, AZ, Pfizer and Novartis to address common challenges with data interchange. Its mission is to standardize data exchange to reduce costs. Current projects include developing standards for semantic enrichment of literature, sequence data services, and electronic lab notebook queries. The organization has over 30 members and operates working groups to develop open standards through a governance process.
Towards a brokering framework for knowledge-based services: Learning from the...Pistoia Alliance
Ian Harrow, co-leader of the Pistoia Alliance SESL pilot, describes the vision for the SESL pilot, the outcomes, and the project's future. The presentation at the 2011 BioITWorld Conference and Expo included a link to the SESL public demonstrator.
Pistoia Alliance SESL pilot Bio IT World Hanover 12 Oct 2011Ian Harrow
Towards a brokering framework for knowledge-based services: learning from the Pistoia Alliance SESL pilot
Ian Harrow PhD for the Pistoia Alliance
This presentation describes a pilot project to determine the feasibility of biomedical knowledge brokering. It shows query across multiple disparate data sources through a brokering demonstrator built from RDF triple store technology. The learning from this pilot is contributing to larger scale projects such as the Innovative Medicines Initiative, OpenPFACTs.
Modeling Service Relationships for Service NetworksJorge Cardoso
The last decade has seen an increased interest in the study of networks in many fields of science. Examples are numerous, from sociology to biology, and to physical systems such as power grids. Nonetheless, the field of service networks has received less attention. Previous research has mainly tackled the modeling of single service systems and service compositions, often focusing only on studying temporal relationships between services. The objective of this paper is to propose a computational model to represent the various types of relationships which can be established between services systems to model service networks. This work acquires a particular importance since the study of service networks can bring new scientific discoveries on how service-based economies operate at a global scale.
Towards a brokering framework for knowledge-based services: Learning from the...Pistoia Alliance
Ian Harrow, co-leader of the Pistoia Alliance SESL pilot, describes the vision for the SESL pilot, the outcomes, and the project's future. The presentation at the 2011 BioITWorld Conference and Expo included a link to the SESL public demonstrator.
Pistoia Alliance SESL pilot Bio IT World Hanover 12 Oct 2011Ian Harrow
Towards a brokering framework for knowledge-based services: learning from the Pistoia Alliance SESL pilot
Ian Harrow PhD for the Pistoia Alliance
This presentation describes a pilot project to determine the feasibility of biomedical knowledge brokering. It shows query across multiple disparate data sources through a brokering demonstrator built from RDF triple store technology. The learning from this pilot is contributing to larger scale projects such as the Innovative Medicines Initiative, OpenPFACTs.
Modeling Service Relationships for Service NetworksJorge Cardoso
The last decade has seen an increased interest in the study of networks in many fields of science. Examples are numerous, from sociology to biology, and to physical systems such as power grids. Nonetheless, the field of service networks has received less attention. Previous research has mainly tackled the modeling of single service systems and service compositions, often focusing only on studying temporal relationships between services. The objective of this paper is to propose a computational model to represent the various types of relationships which can be established between services systems to model service networks. This work acquires a particular importance since the study of service networks can bring new scientific discoveries on how service-based economies operate at a global scale.
The Pistoia Alliance Information Ecosystem WorkshopPistoia Alliance
Michael Braxenthaler, president of the Pistoia Alliance, introduces the concept of the information ecosystem in life science research and discusses the role the Pistoia Alliance can play within this ecosystem. The workshop occurred in October 2011.
Reflections on knowledge management practice case studyRichard Vines
This presentation provides some early reflections of a KM start up project related to Victoria's agricultural sector (Australia) some 16 months after commencement. It also draws upon some work undertaken at the University of Melbourne on the topic of regulatory burden reduction
The Pistoia Alliance: Update on Strategy and ProgressPistoia Alliance
Ramesh Durvasula, Pistoia Alliance board member, discusses the Pistoia Alliance mission and recaps activities in 2011-12, with particular emphasis on the successful completion of the Sequence Squeeze Competition and Sequence Services Phase 2. The presentation was delivered at BioITWorld in Boston in April 2012.
Emerging Life Sciences Collaboration on Common Service SpecificationPistoia Alliance
Presentation by Pistoia Alliance reps Ian Harrow (Pfizer) and Nick Lynch (AstraZeneca) at the International Conference on Trends for Scientific Information Professionals, October 2010.
Sandor Szalma (Janssen) gives an overview of this potential Pistoia Alliance working group during the "Dragons' Den" session of the Pistoia Alliance Conference in Boston, MA, on April 24, 2012.
A set of slides that summarize how MarkLogic is being used in the healthcare industry including case studies on M*Modal and Informatics Corporation of America
The Allotrope Foundation led discussion on building an open framework for laboratory data - recommending a holistic approach to build upon & promote industry standards & best practices by providing software that instantiates them.
Tony Shannon: Health care change in the NHS: Practical considerations of VistANuffield Trust
In this slideshow, Dr Tony Shannon, Consultant in Emergency Medicine and Chief Clinical Information Officer, Leeds Teaching Hospitals, outlines the practical considerations for implementing VistA in the NHS in the context of driving change in people, processes and technology.
Dr Shannon presented at the Nuffield Trust seminar: Sharing international experience: Is implementing the VA's electronic health record system an option for the NHS? in July 2012.
Appalla Venkataprabhakar and I presented this at the Oracle\'s Annual Clinical Development and Safety Conference 2010 at Hyderabad, India on 6th October 2010.
Multiplex Assays in Translational Medicine: Technologies, Applications, and F...ReportLinker.com
The development and growth of assay technologies has pushed translational medicine into a category unto itself. In a broad perspective on this field, this new report:Defines translational medicine by giving some historical background as well as providing personal definitions from experts in the field Discusses the evolution of assay technologies Reviews currently available assay technologies that apply directly to translational medicine Describes and evaluates current applications of these technologies Provides case studies of clinicians currently using this technology in their research Discusses future directions of assay technologies for translational medicine Gives input from the FDA on translation medicine and assay technologies Provides interviews from experts in the field of both translational medicine and specific assay technologies Profiles premier companies active in the field Assay technologies have been evolving since scientists first discovered they could measure glucose, insulin, and several hormones in the blood to help them diagnose disease. Early instruments such as the Ames Reflectance Meter, used for detecting glucose levels, have morphed into such sophisticated systems as flow cytometers. The Human Genome Project provided the basics for researchers to launch into the field of human genomics and they needed the tools to accomplish this. DNA microarrays allowed for massively parallel gene expression analyses. Scientists soon discovered that while the genomewide assays were extremely valuable, there were genes of interest that they had difficulty measuring when they got hundreds of data points from a microarray. Low- to mid-density assays have allowed scientists to pinpoint the genetic code for a variety of uses, from genetic heredity studies to drug metabolism and patient stratification.
The current paradigm in the pharmaceutical industry is that products can only be created and developed by massive collaborative teams. Each company has to build their own costly R&D platforms and IT infrastructure. Other research industries realized decades ago that they had to share data and methods because of cost. The pharmaceutical industry has been slow to realize this. Expanding beyond our recent book (Collaborative Computational Technologies for Biomedical Research) in which a growing number of technologies, consortia, precompetitive initiatives and complex collaboration networks are described, we suggest a more open drug discovery is being enabled by collaborative computational technologies. Academia however, is not training the next generation of scientists to practice open science or even collaborate, this represents challenges and opportunities. We will describe our observations and make recommendations that impact everyone from technology developers to granting agencies. This may enable future discoveries to be made outside traditional institutions.
VAT Registration Outlined In UAE: Benefits and Requirementsuae taxgpt
Vat Registration is a legal obligation for businesses meeting the threshold requirement, helping companies avoid fines and ramifications. Contact now!
https://viralsocialtrends.com/vat-registration-outlined-in-uae/
[Note: This is a partial preview. To download this presentation, visit:
https://www.oeconsulting.com.sg/training-presentations]
Sustainability has become an increasingly critical topic as the world recognizes the need to protect our planet and its resources for future generations. Sustainability means meeting our current needs without compromising the ability of future generations to meet theirs. It involves long-term planning and consideration of the consequences of our actions. The goal is to create strategies that ensure the long-term viability of People, Planet, and Profit.
Leading companies such as Nike, Toyota, and Siemens are prioritizing sustainable innovation in their business models, setting an example for others to follow. In this Sustainability training presentation, you will learn key concepts, principles, and practices of sustainability applicable across industries. This training aims to create awareness and educate employees, senior executives, consultants, and other key stakeholders, including investors, policymakers, and supply chain partners, on the importance and implementation of sustainability.
LEARNING OBJECTIVES
1. Develop a comprehensive understanding of the fundamental principles and concepts that form the foundation of sustainability within corporate environments.
2. Explore the sustainability implementation model, focusing on effective measures and reporting strategies to track and communicate sustainability efforts.
3. Identify and define best practices and critical success factors essential for achieving sustainability goals within organizations.
CONTENTS
1. Introduction and Key Concepts of Sustainability
2. Principles and Practices of Sustainability
3. Measures and Reporting in Sustainability
4. Sustainability Implementation & Best Practices
To download the complete presentation, visit: https://www.oeconsulting.com.sg/training-presentations
More Related Content
Similar to Pistoia presentation bio it-worldexpo 21april2010
The Pistoia Alliance Information Ecosystem WorkshopPistoia Alliance
Michael Braxenthaler, president of the Pistoia Alliance, introduces the concept of the information ecosystem in life science research and discusses the role the Pistoia Alliance can play within this ecosystem. The workshop occurred in October 2011.
Reflections on knowledge management practice case studyRichard Vines
This presentation provides some early reflections of a KM start up project related to Victoria's agricultural sector (Australia) some 16 months after commencement. It also draws upon some work undertaken at the University of Melbourne on the topic of regulatory burden reduction
The Pistoia Alliance: Update on Strategy and ProgressPistoia Alliance
Ramesh Durvasula, Pistoia Alliance board member, discusses the Pistoia Alliance mission and recaps activities in 2011-12, with particular emphasis on the successful completion of the Sequence Squeeze Competition and Sequence Services Phase 2. The presentation was delivered at BioITWorld in Boston in April 2012.
Emerging Life Sciences Collaboration on Common Service SpecificationPistoia Alliance
Presentation by Pistoia Alliance reps Ian Harrow (Pfizer) and Nick Lynch (AstraZeneca) at the International Conference on Trends for Scientific Information Professionals, October 2010.
Sandor Szalma (Janssen) gives an overview of this potential Pistoia Alliance working group during the "Dragons' Den" session of the Pistoia Alliance Conference in Boston, MA, on April 24, 2012.
A set of slides that summarize how MarkLogic is being used in the healthcare industry including case studies on M*Modal and Informatics Corporation of America
The Allotrope Foundation led discussion on building an open framework for laboratory data - recommending a holistic approach to build upon & promote industry standards & best practices by providing software that instantiates them.
Tony Shannon: Health care change in the NHS: Practical considerations of VistANuffield Trust
In this slideshow, Dr Tony Shannon, Consultant in Emergency Medicine and Chief Clinical Information Officer, Leeds Teaching Hospitals, outlines the practical considerations for implementing VistA in the NHS in the context of driving change in people, processes and technology.
Dr Shannon presented at the Nuffield Trust seminar: Sharing international experience: Is implementing the VA's electronic health record system an option for the NHS? in July 2012.
Appalla Venkataprabhakar and I presented this at the Oracle\'s Annual Clinical Development and Safety Conference 2010 at Hyderabad, India on 6th October 2010.
Multiplex Assays in Translational Medicine: Technologies, Applications, and F...ReportLinker.com
The development and growth of assay technologies has pushed translational medicine into a category unto itself. In a broad perspective on this field, this new report:Defines translational medicine by giving some historical background as well as providing personal definitions from experts in the field Discusses the evolution of assay technologies Reviews currently available assay technologies that apply directly to translational medicine Describes and evaluates current applications of these technologies Provides case studies of clinicians currently using this technology in their research Discusses future directions of assay technologies for translational medicine Gives input from the FDA on translation medicine and assay technologies Provides interviews from experts in the field of both translational medicine and specific assay technologies Profiles premier companies active in the field Assay technologies have been evolving since scientists first discovered they could measure glucose, insulin, and several hormones in the blood to help them diagnose disease. Early instruments such as the Ames Reflectance Meter, used for detecting glucose levels, have morphed into such sophisticated systems as flow cytometers. The Human Genome Project provided the basics for researchers to launch into the field of human genomics and they needed the tools to accomplish this. DNA microarrays allowed for massively parallel gene expression analyses. Scientists soon discovered that while the genomewide assays were extremely valuable, there were genes of interest that they had difficulty measuring when they got hundreds of data points from a microarray. Low- to mid-density assays have allowed scientists to pinpoint the genetic code for a variety of uses, from genetic heredity studies to drug metabolism and patient stratification.
The current paradigm in the pharmaceutical industry is that products can only be created and developed by massive collaborative teams. Each company has to build their own costly R&D platforms and IT infrastructure. Other research industries realized decades ago that they had to share data and methods because of cost. The pharmaceutical industry has been slow to realize this. Expanding beyond our recent book (Collaborative Computational Technologies for Biomedical Research) in which a growing number of technologies, consortia, precompetitive initiatives and complex collaboration networks are described, we suggest a more open drug discovery is being enabled by collaborative computational technologies. Academia however, is not training the next generation of scientists to practice open science or even collaborate, this represents challenges and opportunities. We will describe our observations and make recommendations that impact everyone from technology developers to granting agencies. This may enable future discoveries to be made outside traditional institutions.
VAT Registration Outlined In UAE: Benefits and Requirementsuae taxgpt
Vat Registration is a legal obligation for businesses meeting the threshold requirement, helping companies avoid fines and ramifications. Contact now!
https://viralsocialtrends.com/vat-registration-outlined-in-uae/
[Note: This is a partial preview. To download this presentation, visit:
https://www.oeconsulting.com.sg/training-presentations]
Sustainability has become an increasingly critical topic as the world recognizes the need to protect our planet and its resources for future generations. Sustainability means meeting our current needs without compromising the ability of future generations to meet theirs. It involves long-term planning and consideration of the consequences of our actions. The goal is to create strategies that ensure the long-term viability of People, Planet, and Profit.
Leading companies such as Nike, Toyota, and Siemens are prioritizing sustainable innovation in their business models, setting an example for others to follow. In this Sustainability training presentation, you will learn key concepts, principles, and practices of sustainability applicable across industries. This training aims to create awareness and educate employees, senior executives, consultants, and other key stakeholders, including investors, policymakers, and supply chain partners, on the importance and implementation of sustainability.
LEARNING OBJECTIVES
1. Develop a comprehensive understanding of the fundamental principles and concepts that form the foundation of sustainability within corporate environments.
2. Explore the sustainability implementation model, focusing on effective measures and reporting strategies to track and communicate sustainability efforts.
3. Identify and define best practices and critical success factors essential for achieving sustainability goals within organizations.
CONTENTS
1. Introduction and Key Concepts of Sustainability
2. Principles and Practices of Sustainability
3. Measures and Reporting in Sustainability
4. Sustainability Implementation & Best Practices
To download the complete presentation, visit: https://www.oeconsulting.com.sg/training-presentations
The world of search engine optimization (SEO) is buzzing with discussions after Google confirmed that around 2,500 leaked internal documents related to its Search feature are indeed authentic. The revelation has sparked significant concerns within the SEO community. The leaked documents were initially reported by SEO experts Rand Fishkin and Mike King, igniting widespread analysis and discourse. For More Info:- https://news.arihantwebtech.com/search-disrupted-googles-leaked-documents-rock-the-seo-world/
LA HUG - Video Testimonials with Chynna Morgan - June 2024Lital Barkan
Have you ever heard that user-generated content or video testimonials can take your brand to the next level? We will explore how you can effectively use video testimonials to leverage and boost your sales, content strategy, and increase your CRM data.🤯
We will dig deeper into:
1. How to capture video testimonials that convert from your audience 🎥
2. How to leverage your testimonials to boost your sales 💲
3. How you can capture more CRM data to understand your audience better through video testimonials. 📊
Falcon stands out as a top-tier P2P Invoice Discounting platform in India, bridging esteemed blue-chip companies and eager investors. Our goal is to transform the investment landscape in India by establishing a comprehensive destination for borrowers and investors with diverse profiles and needs, all while minimizing risk. What sets Falcon apart is the elimination of intermediaries such as commercial banks and depository institutions, allowing investors to enjoy higher yields.
RMD24 | Retail media: hoe zet je dit in als je geen AH of Unilever bent? Heid...BBPMedia1
Grote partijen zijn al een tijdje onderweg met retail media. Ondertussen worden in dit domein ook de kansen zichtbaar voor andere spelers in de markt. Maar met die kansen ontstaan ook vragen: Zelf retail media worden of erop adverteren? In welke fase van de funnel past het en hoe integreer je het in een mediaplan? Wat is nu precies het verschil met marketplaces en Programmatic ads? In dit half uur beslechten we de dilemma's en krijg je antwoorden op wanneer het voor jou tijd is om de volgende stap te zetten.
Affordable Stationery Printing Services in Jaipur | Navpack n PrintNavpack & Print
Looking for professional printing services in Jaipur? Navpack n Print offers high-quality and affordable stationery printing for all your business needs. Stand out with custom stationery designs and fast turnaround times. Contact us today for a quote!
Memorandum Of Association Constitution of Company.pptseri bangash
www.seribangash.com
A Memorandum of Association (MOA) is a legal document that outlines the fundamental principles and objectives upon which a company operates. It serves as the company's charter or constitution and defines the scope of its activities. Here's a detailed note on the MOA:
Contents of Memorandum of Association:
Name Clause: This clause states the name of the company, which should end with words like "Limited" or "Ltd." for a public limited company and "Private Limited" or "Pvt. Ltd." for a private limited company.
https://seribangash.com/article-of-association-is-legal-doc-of-company/
Registered Office Clause: It specifies the location where the company's registered office is situated. This office is where all official communications and notices are sent.
Objective Clause: This clause delineates the main objectives for which the company is formed. It's important to define these objectives clearly, as the company cannot undertake activities beyond those mentioned in this clause.
www.seribangash.com
Liability Clause: It outlines the extent of liability of the company's members. In the case of companies limited by shares, the liability of members is limited to the amount unpaid on their shares. For companies limited by guarantee, members' liability is limited to the amount they undertake to contribute if the company is wound up.
https://seribangash.com/promotors-is-person-conceived-formation-company/
Capital Clause: This clause specifies the authorized capital of the company, i.e., the maximum amount of share capital the company is authorized to issue. It also mentions the division of this capital into shares and their respective nominal value.
Association Clause: It simply states that the subscribers wish to form a company and agree to become members of it, in accordance with the terms of the MOA.
Importance of Memorandum of Association:
Legal Requirement: The MOA is a legal requirement for the formation of a company. It must be filed with the Registrar of Companies during the incorporation process.
Constitutional Document: It serves as the company's constitutional document, defining its scope, powers, and limitations.
Protection of Members: It protects the interests of the company's members by clearly defining the objectives and limiting their liability.
External Communication: It provides clarity to external parties, such as investors, creditors, and regulatory authorities, regarding the company's objectives and powers.
https://seribangash.com/difference-public-and-private-company-law/
Binding Authority: The company and its members are bound by the provisions of the MOA. Any action taken beyond its scope may be considered ultra vires (beyond the powers) of the company and therefore void.
Amendment of MOA:
While the MOA lays down the company's fundamental principles, it is not entirely immutable. It can be amended, but only under specific circumstances and in compliance with legal procedures. Amendments typically require shareholder
What is the TDS Return Filing Due Date for FY 2024-25.pdfseoforlegalpillers
It is crucial for the taxpayers to understand about the TDS Return Filing Due Date, so that they can fulfill your TDS obligations efficiently. Taxpayers can avoid penalties by sticking to the deadlines and by accurate filing of TDS. Timely filing of TDS will make sure about the availability of tax credits. You can also seek the professional guidance of experts like Legal Pillers for timely filing of the TDS Return.
Buy Verified PayPal Account | Buy Google 5 Star Reviewsusawebmarket
Buy Verified PayPal Account
Looking to buy verified PayPal accounts? Discover 7 expert tips for safely purchasing a verified PayPal account in 2024. Ensure security and reliability for your transactions.
PayPal Services Features-
🟢 Email Access
🟢 Bank Added
🟢 Card Verified
🟢 Full SSN Provided
🟢 Phone Number Access
🟢 Driving License Copy
🟢 Fasted Delivery
Client Satisfaction is Our First priority. Our services is very appropriate to buy. We assume that the first-rate way to purchase our offerings is to order on the website. If you have any worry in our cooperation usually You can order us on Skype or Telegram.
24/7 Hours Reply/Please Contact
usawebmarketEmail: support@usawebmarket.com
Skype: usawebmarket
Telegram: @usawebmarket
WhatsApp: +1(218) 203-5951
USA WEB MARKET is the Best Verified PayPal, Payoneer, Cash App, Skrill, Neteller, Stripe Account and SEO, SMM Service provider.100%Satisfection granted.100% replacement Granted.
Premium MEAN Stack Development Solutions for Modern BusinessesSynapseIndia
Stay ahead of the curve with our premium MEAN Stack Development Solutions. Our expert developers utilize MongoDB, Express.js, AngularJS, and Node.js to create modern and responsive web applications. Trust us for cutting-edge solutions that drive your business growth and success.
Know more: https://www.synapseindia.com/technology/mean-stack-development-company.html
Putting the SPARK into Virtual Training.pptxCynthia Clay
This 60-minute webinar, sponsored by Adobe, was delivered for the Training Mag Network. It explored the five elements of SPARK: Storytelling, Purpose, Action, Relationships, and Kudos. Knowing how to tell a well-structured story is key to building long-term memory. Stating a clear purpose that doesn't take away from the discovery learning process is critical. Ensuring that people move from theory to practical application is imperative. Creating strong social learning is the key to commitment and engagement. Validating and affirming participants' comments is the way to create a positive learning environment.
Personal Brand Statement:
As an Army veteran dedicated to lifelong learning, I bring a disciplined, strategic mindset to my pursuits. I am constantly expanding my knowledge to innovate and lead effectively. My journey is driven by a commitment to excellence, and to make a meaningful impact in the world.
1. The Pistoia
Alliance
pistoiaalliance.org
A Construct for Pre-competitive
Collaboration and Open Innovation
Ramesh Durvasula, Ph.D.
Communications Officer, Pistoia Alliance
Director, Chemistry Informatics, BMS
BioIT World
2010
2. Agenda
• Origins of Pistoia
– History
– Industry Drivers
– Technology Trends
• Scope and Operations of Pistoia
– Mission, Membership, Governance
– Projects and Deliverables
• Discussion
3. Industry Driver: Externalization
Cost pressures, disruptive technologies, and other forces
often drive business processes to be externalized.
Fully Internal
Model
Selectively
PHARMA
Integrated
CHEM CRO
Model
BIO CRO
DATA CRO
6. Greater Challenge: Unknown Semantic
Collisions
Image/quote from Abdul-Malik Shakir
Revealing assumptions is an essential
component of effective communication.
7. Opportunity: Changing Tech
Landscape
More Robust Technologies
• Web 2.0 / 3.0
• Services-Oriented Architecture
• Software-as-a-Service
• Open Source Initiatives
More Robust External Content
• Publicly available chem and bio sources
• Richer literature content
• Academic Sources of Tools and Data
8. The Path Forward:
Standardize, Simplify, Centralize
• Standardize our interfaces and
messages
• Simplify our cross-industry
architectures and support models
• Centralize services to reap economies
of scale and scope
9. Background—How it all started
• In Pistoia, Italy
• Meeting of GSK, AZ,
Pfizer and Novartis—
identified similar
challenges and
frustrations in discovery
informatics
9
10. Pistoia Mission
• The Mission
– Pistoia will standardize and streamline data
interchange in life science R&D.
• The Method
– Precompetitive collaboration between life science,
academia, and commercial partners.
• The Result
– Standardization will drive down the cost of data
exchange, cloud computing, and process outsourcing.
• The Benefit
– Informatics organizations can streamline commodity
services, and focus investment on innovation in R&D.
11. Benefits of Pistoia
• R&D Organizations
– Optimized investments
• e.g. reduction of redundant investments across industry
– Increased agility to leverage global R&D
• Rapid integration, streamlined data interchange and
analysis
• Informatics Solution Providers
– New markets and business models
– Reduced cost-of-entry to markets
– Reduction of customized solutions, leading to
higher margins
13. Pre-competitive Space in the
Technology Lifecycle
Experiment
Innovation
Mainstream Precompetitive Space
Opportunities for Standards
Commodity
Legacy
14. Crossing the Chasm
• Pistoia is the BRIDGE to cross the chasm
to a more agile pre-competitive
environment
STANDARDIZE SIMPLIFY CENTRALIZE
PISTOIA MEMBERS SUPPLIERS
15. Learn from Other Industries
Transportation
Geospatial
Banking
Retail Clinical
Automotive
Healthcare
16. Scope of Pistoia Efforts
Target ID Hit ID Lead ID Lead Opt Phase I Phase II Phase III
Which Disease?
Which Target? Which Compound?
What Biomarkers?
Disease Association DMPK Properties? CD positioning?
Bioprocess Assoc BioAssay Development Safety Biomarkers?
Druggability Activity-Dose studies? Efficacy Biomarkers?
‘On Target’ Safety Risk ‘Off Target’ Safety Risk? …
Validation Tools Synthesis routes?
Competitive Position Competitive Position?
Variant Selection …
…
Genome/Genetic Data Genome/Genetic Data
Sequence Data
Expression Data Structural Data
Pathway Data
Patent Data
Pharmacology Data
Literature Data
16
17. Pistoia Standards Process
Governance & Pistoia Working Life Science
Operations Groups Community
Governance Software and
& Strategy Service
Board Providers
propose,
Technical & comment
Standards Pharma/
Operational Teams BioTech/Agro
Team publish
Not for
coordinate Profit
(e.g. IMI, EBI)
17
18. Current, Active Pistoia Projects
• Semantic Enrichment of Scientific Literature
– An open knowledge brokering framework standard which will
reduce the costs of integration from disparate sources.
• Sequence Services
– A standard service to provide access to public, private &
commercial data & tools, that will enable scientists to search,
store & analyse all their sequence based data in a single web
interface.
• ELN Query Service
– A query service standard applicable for use with data types
commonly found in electronic lab notebooks
19. SESL: Biomedical Knowledge Service
Framework
Multiple
Consumers
Target Compound Disease Network Knowledge
Dossier Dossier Dossier Viz Applications
Service Layer Std Public Common
Proprietary
Open Assertion & Meta Data Mgmt Vocabularies Service
Service
Stds Transform / Translate Business Broker
Broker
Consumer Integrator Rules
Firewall
Supplier Content
Firewall Suppliers
Db 2
Effort required
Db 4 to fit DBs to
Corpus 1 service layer
Db 3 Corpus 5
20. A Production SESL Service
Consumer Exemplar
Disease Dossier
Side Application
License
Service Layer Std Public Service Layer Std Public Service Layer Std Public Service Layer Std Public
Vocabularies Vocabularies Vocabularies Vocabularies
Assertion & Meta Data Mgmt Assertion & Meta Data Mgmt Assertion & Meta Data Mgmt Assertion & Meta Data Mgmt
Transform / Translate Business Transform / Translate Business Transform / Translate Business Transform / Translate Business
Rules Rules Rules Rules
Integrator Integrator Integrator Integrator
Broker Org #1 Broker Org #2 Broker Org #3 Broker Org #4
Corpus 1 Db 3 Corpus 5 Db 7 Corpus 9 Db 11 Corpus 13 Db 15
Corpus 4 Corpus 8 Corpus 12 Corpus 16
Db 2 Db 6 Db 10 Db 14
Supplier
Side
21. SESL Mock Up Slide 1
Gene: abc
Relationship: Any
Disease: Diabetes
Constraint: Species: Any
Tissue: Any
22. SESL Mock Up Slide 2
Export to Network View
Pivot on Assertion
Gene R’ship Disease Species Evidence
1 abc1 Co-occurs Diabetes Mus Paper UID:1234
2 abc1 Up-Reg Diabetes Homo ArrayExpress: XXX
3 abc2 Co-occurs Diabetes Homo Paper UID:1344
4 abc13 Co-occurs Diabetes Mus Paper UID:1314
5 abc7 Mutation Diabetes Rattus OMIMI: XXX
6 abc1 Co-occurs Diabetes Mus Paper UID:45643
7 abc1 Co-occurs Diabetes Homo Paper UID:2143
8 abc1 Co-occurs Diabetes Mus Paper UID:1204
24. Current SESL Participants
AstraZeneca Funding
GSK Funding
Roche Funding
Pfizer Funding
Unilever FTEs
European Bioinformatics Institute FTEs & Hosting
Oxford University Press Content
Nature Publishing Group Content
Elsevier Content
Royal Society of Chemistry Content
28. Who we Are: Board of Directors
GSK Accelrys
AZ ChemAxon
Novartis Symyx
Pfizer CambridgeSoft
Lundbeck Infosys
BMS Thomson Reuters
Roche
29. Pistoia Membership Levels
• Core Member ($15,000)
– Those organisations wishing to strongly influence the strategy &
direction of the Alliance
– Have a majority on the Governance & Strategy Board
– Pharma, Life Science, Chemicals/Biologics primary business focus
• Participating Member ($10,000)
– Those wishing to influence the technical outcomes
– Access to Governance & Strategy Board member openings
– Technical & Standards Team voting
• Contributing Member (free)
– Technical & Standards Team voting member
– Working Group participation
– Offer opinions on technical issues
Based around the experiences of: http://www.consortiuminfo.org/